Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,731,547 papers from all fields of science
Search
Sign In
Create Free Account
Furegrelate Sodium
Known as:
2-Benzofurancarboxylic acid, 5-(3-pyridinylmethyl)-, Sodium Salt, Monohydrate
, Sodium 5-(3-pyridylmethyl)-2-benzofurancarboxylate Monohydrate
, U-63,557A
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
The association of in vitro arachidonic acid responsiveness and plasma thromboxane levels with early platelet deposition on the luminal surface of small-diameter grafts.
M. Freeman
,
G. Sicard
,
L. I. Valentin
,
S. Neuberger
,
M. Mangino
,
C. Anderson
Journal of Vascular Surgery
1988
Corpus ID: 25197851
1987
1987
Renal microthrombosis following endotoxin infusion may be mediated by lipoxygenase products.
R. Schaub
,
R. Ochoa
,
C. Simmons
,
K. Lincoln
Circulatory shock
1987
Corpus ID: 9208514
Renal microvascular thrombosis following endotoxin infusion was assessed by measuring accumulation of 125I-labeled fibrinogen and…
Expand
1987
1987
Testing the "redirection hypothesis" of prostaglandin metabolism in the kidney.
S. Datar
,
F. A. McCauley
,
T. Wilson
Prostaglandins
1987
Corpus ID: 21336038
1985
1985
Protective action of a thromboxane synthetase inhibitor in preventing extension of infarct size in acute myocardial infarction.
C. E. Hock
,
G. Phillips
,
A. M. Lefer
Prostaglandins Leukotrienes and Medicine
1985
Corpus ID: 27232777
1984
1984
Beneficial effect of a thromboxane synthetase inhibitor in traumatic shock.
C. E. Hock
,
A. M. Lefer
Circulatory shock
1984
Corpus ID: 44285140
Traumatic shock was induced in anesthetized rats using the Noble-Collip method. This resulted in an abrupt decline in mean…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE